157 related articles for article (PubMed ID: 7986398)
1. Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers.
Barry M; Wild M; Veal G; Back D; Breckenridge A; Fox R; Beeching N; Nye F; Carey P; Timmins D
AIDS; 1994 Aug; 8(8):F1-5. PubMed ID: 7986398
[TBL] [Abstract][Full Text] [Related]
2. The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites.
Barry MG; Khoo SH; Veal GJ; Hoggard PG; Gibbons SE; Wilkins EG; Williams O; Breckenridge AM; Back DJ
AIDS; 1996 Oct; 10(12):1361-7. PubMed ID: 8902065
[TBL] [Abstract][Full Text] [Related]
3. Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure.
Slusher JT; Kuwahara SK; Hamzeh FM; Lewis LD; Kornhauser DM; Lietman PS
Antimicrob Agents Chemother; 1992 Nov; 36(11):2473-7. PubMed ID: 1489190
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults.
Anderson PL; Zheng JH; King T; Bushman LR; Predhomme J; Meditz A; Gerber J; Fletcher CV
AIDS; 2007 Sep; 21(14):1849-54. PubMed ID: 17721092
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of zidovudine phosphorylation in human immunodeficiency virus-positive thai patients and healthy volunteers.
Wattanagoon Y; Na Bangchang K; Hoggard PG; Khoo SH; Gibbons SE; Phiboonbhanakit D; Karbwang J; Back DJ
Antimicrob Agents Chemother; 2000 Jul; 44(7):1986-9. PubMed ID: 10858368
[TBL] [Abstract][Full Text] [Related]
6. In vitro measurement of phosphorylated zidovudine in peripheral blood leucocytes.
Stretcher BN; Pesce AJ; Wermeling JR; Hurtubise PE
Ther Drug Monit; 1990 Sep; 12(5):481-9. PubMed ID: 2293412
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of zidovudine triphosphate concentrations from human peripheral blood mononuclear cells by anion exchange solid phase extraction and liquid chromatography-tandem mass spectroscopy; an indirect quantitation methodology.
King T; Bushman L; Anderson PL; Delahunty T; Ray M; Fletcher CV
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):248-57. PubMed ID: 16412710
[TBL] [Abstract][Full Text] [Related]
8. Determination of zidovudine triphosphate intracellular concentrations in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals by tandem mass spectrometry.
Font E; Rosario O; Santana J; García H; Sommadossi JP; Rodriguez JF
Antimicrob Agents Chemother; 1999 Dec; 43(12):2964-8. PubMed ID: 10582890
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantitation of the 5'-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry.
Moore JD; Valette G; Darque A; Zhou XJ; Sommadossi JP
J Am Soc Mass Spectrom; 2000 Dec; 11(12):1134-43. PubMed ID: 11118121
[TBL] [Abstract][Full Text] [Related]
10. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
Moore JD; Acosta EP; Johnson VA; Bassett R; Eron JJ; Fischl MA; Long MC; Kuritzkes DR; Sommadossi JP
Antivir Ther; 2007; 12(6):981-6. PubMed ID: 17926654
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated zidovudine concentrations in mononuclear cells in pediatric patients with human immunodeficiency virus infections.
Wintermeyer SM; Nahata MC; Brady MT; Sobol BJ; Venglarcik JS 3rd ; Baker RC; Hunkler JA; McOwen NM
Pediatr AIDS HIV Infect; 1997 Apr; 8(2):120-6. PubMed ID: 11361778
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells.
Robbins BL; Rodman J; McDonald C; Srinivas RV; Flynn PM; Fridland A
Antimicrob Agents Chemother; 1994 Jan; 38(1):115-21. PubMed ID: 7511360
[TBL] [Abstract][Full Text] [Related]
13. Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study.
Chen J; Flexner C; Liberman RG; Skipper PL; Louissaint NA; Tannenbaum SR; Hendrix CW; Fuchs EJ
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):593-9. PubMed ID: 23187888
[TBL] [Abstract][Full Text] [Related]
14. Ultrasensitive method to quantify intracellular zidovudine mono-, di- and triphosphate concentrations in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry.
Kinai E; Gatanaga H; Kikuchi Y; Oka S; Kato S
J Mass Spectrom; 2015 Jun; 50(6):783-91. PubMed ID: 26169132
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals.
Rodriguez JF; Rodriguez JL; Santana J; García H; Rosario O
Antimicrob Agents Chemother; 2000 Nov; 44(11):3097-100. PubMed ID: 11036029
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of phosphorylated zidovudine (ZDV) in patient leukocytes do not correlate with ZDV dose or plasma concentrations.
Stretcher BN; Pesce AJ; Murray JA; Hurtubise PE; Vine WH; Frame PT
Ther Drug Monit; 1991 Jul; 13(4):325-31. PubMed ID: 1780965
[TBL] [Abstract][Full Text] [Related]
17. Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine.
Rower JE; Meditz A; Gardner EM; Lichtenstein K; Predhomme J; Bushman LR; Klein B; Zheng JH; Mawhinney S; Anderson PL
Antimicrob Agents Chemother; 2012 Jun; 56(6):3011-9. PubMed ID: 22391541
[TBL] [Abstract][Full Text] [Related]
18. A method for the quantification of intracellular zidovudine nucleotides.
Kuster H; Vogt M; Joos B; Nadai V; Lüthy R
J Infect Dis; 1991 Oct; 164(4):773-6. PubMed ID: 1894938
[TBL] [Abstract][Full Text] [Related]
19. A sensitive nonisotopic method for the determination of intracellular azidothymidine 5'-mono-, 5'-di-, and 5'-triphosphate.
Toyoshima T; Kimura S; Muramatsu S; Takahagi H; Shimada K
Anal Biochem; 1991 Aug; 196(2):302-7. PubMed ID: 1776679
[TBL] [Abstract][Full Text] [Related]
20. Zidovudine phosphorylation determined sequentially over 12 months in human immunodeficiency virus-infected patients with or without previous exposure to antiretroviral agents.
Hoggard PG; Lloyd J; Khoo SH; Barry MG; Dann L; Gibbons SE; Wilkins EG; Loveday C; Back DJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):976-80. PubMed ID: 11181396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
